- Report
- December 2021
- 296 Pages
Global
From €2390EUR$2,625USD£2,050GBP
€4780EUR$5,250USD£4,101GBP
- Report
- December 2021
- 226 Pages
Global
From €2390EUR$2,625USD£2,050GBP
€4780EUR$5,250USD£4,101GBP
- Report
- May 2024
- 200 Pages
Global
From €3779EUR$4,150USD£3,241GBP
- Report
- November 2024
- 165 Pages
Global
From €2276EUR$2,500USD£1,953GBP
- Report
- June 2021
- 77 Pages
Global
From €4507EUR$4,950USD£3,866GBP
- Report
- April 2025
- 239 Pages
Global
From €2276EUR$2,500USD£1,953GBP
- Report
- December 2024
- 159 Pages
Asia Pacific
From €2276EUR$2,500USD£1,953GBP
- Report
- July 2024
- 136 Pages
Global
From €2276EUR$2,500USD£1,953GBP
- Report
- July 2024
- 80 Pages
Japan
From €3187EUR$3,500USD£2,734GBP
- Report
- November 2023
- 77 Pages
France
From €3187EUR$3,500USD£2,734GBP
- Report
- November 2023
- 88 Pages
Germany
From €3187EUR$3,500USD£2,734GBP
- Report
- October 2023
- 82 Pages
United Kingdom
From €3642EUR$4,000USD£3,124GBP
From €3187EUR$3,500USD£2,734GBP
- Report
- September 2025
- 185 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Report
- August 2025
- 185 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Report
- August 2025
- 130 Pages
Asia Pacific
From €3642EUR$4,000USD£3,124GBP
- Report
- August 2025
- 180 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Report
- July 2025
- 188 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Report
- July 2025
- 188 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Report
- July 2025
- 177 Pages
Global
From €4097EUR$4,500USD£3,515GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more